Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Cancer Gene Therapy|July 30, 2016
Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancerH Sawahara, H Shiraha, D Uchida, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 12, 1999
[A comparative study of a thick and standard loop in transurethral resection of the prostate]H Hashimoto, M Tsugawa, Y Nasu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Elevated expression of caveolin is associated with prostate and breast cancerG Yang, L D Truong, T L Timme, et al.
Japanese Journal of Clinical Oncology|December 16, 2020
Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 studyK Kobayashi, N Okuno, G Arai, et al.
Oncogene|September 12, 2012
The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cellsR Koyama-Nasu, Y Nasu-Nishimura, T Todo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccinesG W Hull, M A Mccurdy, Y Nasu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 16, 1998
Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative studyM Kuriyama, K Ueno, H Uno, et al.
Oncogene|May 21, 2013
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cellsR Koyama-Nasu, R Haruta, Y Nasu-Nishimura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 18, 1998
[Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer]Y Maki, T Tsushima, Y Nasu, et al.
Pageof 11